- Alkido Pharma's ( NASDAQ: AIKI ) significant stockholder Shalom Auerbach, who owns ~3.8% of its stock, announced that he has sent a letter proposing to acquire the company for $8/share in cash.
- This proposal to buy AIKI represents a 31% premium to the company’s most recent closing share price on Aug.8, 2022.
- It will provide substantial and immediate cash value for stockholders.
- The shareholder indicates that he will not hold this proposal open indefinitely and it is critical that the company meets with him by no later than Aug.23, 2022.
For further details see:
Alkido Pharma shareholders proposes to acquire company at $8/share in cash